Navigation Links
Eppendorf Video Features Dr Andrew Holt's Work on Bioactive Leachates From Plastic Consumables
Date:12/2/2011

HAMBURG, Germany, December 2, 2011 /PRNewswire/ --

Cross reference: Picture is available via epa european pressphoto agency and can be downloaded free of charge at: http://www.presseportal.de/pm/18701/eppendorf-ag?keygroup=bild

In a well-received report in Science from 2008, Dr. Andrew Holt and his group from the University of Alberta, Canada, described how chemicals used as manufacturing additives can substantially inhibit enzymatic assays and binding studies by leaching into samples from plastic consumables. Eppendorf recently visited Dr. Holt's pharmacology lab with a film crew to ask him how experimental data can be affected and what he recommends to other scientists to ensure unaffected and reproducible results.

Daniel Wehrhahn, product manager responsible for consumables at Eppendorf, commented: 'Dr. Holt's results clearly show that using pipette tips and microcentrifuge tubes from manufacturers that can confirm the absence of critical production additives leads to experimental results which are much more reliable and reproducible. Eppendorf high quality consumables are manufactured only from virgin polypropylene certified free of plasticizers, biocides or other unwanted additives which could leach into buffers and solvents, leading to false positive or false negative results in bioassays. Our material also complies with the FDA requirements for olefin polymers.'

Launched via the Eppendorf consumables web page, YouTube and social networking sites, the new video will quickly gain worldwide exposure, helping other researchers choose plastic consumables which are best suited to their assays. Scientific background information, recent publications and application data is also available on the website.  

Eppendorf's clean-room manufacturing processes are fully automated and subject to continuous quality monitoring. In addition, fully-automated production and special optimised molds that work without slip agents - such as Oleamide or DiHEMDA - ensure that epT.I.P.S. pipette tips®, Eppendorf Tubes® and Eppendorf Plates® satisfy the requirements of demanding applications. Batch-specific purity certificates can be downloaded from the Eppendorf website.

http://www.eppendorf.com/consumables

A Video interview with Dr. Andrew Holt is available at:

http://www.youtube.com/watch?v=LR1ljpp9TDE

 

Press contact:
Eppendorf AG
Bettina Doerler
public relations officer
doerler.b@eppendorf.de
+49-40-538-01-640



'/>"/>
SOURCE Eppendorf AG
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Eppendorf Successfully Initiates Import ban Against Nanosphere, Inc. for the Countries of the European Union
2. Eppendorf Licenses Technology for Thermal Cyclers to Bulldog Bio
3. Eppendorf AG Deploys a Strategic Information Management Solution on a Global Level
4. [video] Jacques Tizabi, CEO of Universal Detection Technology Discusses Latest Purchase Order on WallSt.nets 3-Minute Press Show
5. [video] David Brown, President and CEO of LifeVantage Corporation, Discusses Record Page Views on WallSt.nets 3-Minute Press Show
6. Video: CSL Behring Provides $1.2M Grant for Worlds First Study of Postpartum Women with VWD, Common Bleeding Disorder
7. Video: ASMANEX(R) TWISTHALER(R) 110 MCG (Mometasone Furoate Inhalation Powder) is Now Available Nationwide for the Maintenance Treatment of Asthma in Children Ages 4 to 11
8. Video: New Survey Shows Three in Four School Nurses Have Students at Risk for Severe Allergic Reactions Who Do Not Bring Auto-Injectable Epinephrine to School
9. Caliper Launches Small Animal Molecular Imaging System Enabling Real-Time Video Observation
10. Video: Keppra XR(TM) Approved in the U.S.
11. Video: Fortune 1000 Executives: New President Must Fix Education Gap
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... , Feb. 24, 2017 Provectus Biopharmaceuticals, ... the "Company"), a clinical-stage oncology and dermatology biopharmaceutical ... deadline to participate in its previously announced rights ... of shares of common stock and Series C ... of listed warrants. As previously ...
(Date:2/24/2017)... Cord Blood Corporation (NYSE: CO ) ("CCBC" ... collection, laboratory testing, hematopoietic stem cell processing and stem ... for the third quarter and first nine months of ... Third Quarter of Fiscal 2017 Highlights ... by 18.6% to RMB200.9 million ($28.9 million). ...
(Date:2/24/2017)... DIEGO , Feb. 24, 2017  OncoSec Medical ... cancer immunotherapies, will host a Key Opinion Leader event ... as an oral and poster presentation at the upcoming ... plan. The KOL event will be held in-person and ... PM EST / 9:00 AM PST at the Lotte ...
(Date:2/23/2017)... /PRNewswire/ - The Fight Against Cancer Innovation Trust (FACIT) ... pleased to report that Fusion Pharmaceuticals Inc. (Fusion) has ... Johnson Innovation – JJDC, Inc. (JJDC) as the lead ... Biotechnology Partners, and Genesys Capital, as well as founding ... ...
Breaking Biology Technology:
(Date:2/13/2017)... Feb. 13, 2017  RSA Conference -- RSA, a ... is designed to enhance fraud detection and investigation ... the RSA Fraud & Risk Intelligence Suite. The ... leverage additional insights from internal and external sources ... protect their customers from targeted cybercrime attacks. ...
(Date:2/8/2017)... 8, 2017 About Voice Recognition Biometrics Voice ... it against a stored voiceprint template. Acoustic features ... and tone are compared to distinguish between individual ... as most PCs already have a microphone and ... recognition biometrics are most likely to be deployed ...
(Date:2/8/2017)... LONDON , Feb. 7, 2017 Report ... $12.5 billion by 2021 from $8.3 billion in 2016 ... from 2016 to 2021. Report Includes - An ... of global market trends, with data from 2015 and ... through 2021. - Segmentation of the market on the ...
Breaking Biology News(10 mins):